Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 01, 2021

SELL
$216.38 - $257.67 $3.4 Million - $4.04 Million
-15,696 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $741,494 - $824,602
3,160 Added 25.21%
15,696 $3.99 Million
Q2 2020

Jul 30, 2020

BUY
$197.81 - $242.74 $2.48 Million - $3.04 Million
12,536 New
12,536 $2.96 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Value Partners Investments Inc. Portfolio

Follow Value Partners Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Value Partners Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Value Partners Investments Inc. with notifications on news.